David J. Heal

BioCity, Pennyfoot Street
Nottingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Psychedelic research - Going global.

Psychedelic research - Going global.

Journal: Journal of psychopharmacology (Oxford, England)

Published: December 01, 2025

Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations.

Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations.

Journal: Journal of psychopharmacology (Oxford, England)

Published: November 04, 2025

Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.

Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.

Journal: Journal of psychopharmacology (Oxford, England)

Published: October 16, 2025

Nalfurafine is Aversive at Antinociceptive Doses in Mice.

Nalfurafine is Aversive at Antinociceptive Doses in Mice.

Journal: Pharmacology research & perspectives

Published: May 19, 2025

Discriminating evidence - use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs.

Discriminating evidence - use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs.

Journal: Journal of psychopharmacology (Oxford, England)

Published: April 17, 2025

Electrophysiological analysis of paraventricular thalamic neurons co-expressing kappa and mu opioid receptors.

Electrophysiological analysis of paraventricular thalamic neurons co-expressing kappa and mu opioid receptors.

Journal: Neuropharmacology

Published: January 20, 2025

Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder.

Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder.

Journal: Advances in pharmacology (San Diego, Calif.)

Published: March 11, 2024

Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuse.

Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuse.

Journal: Neuropharmacology

Published: November 21, 2023

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.

Journal: Frontiers in psychiatry

Published: October 16, 2023

Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments.

Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments.

Journal: Handbook of experimental pharmacology

Published: July 26, 2023

Psychedelics: Threshold of a Therapeutic Revolution.

Psychedelics: Threshold of a Therapeutic Revolution.

Journal: Neuropharmacology

Published: May 29, 2023

Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.

Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.

Journal: Journal of psychopharmacology (Oxford, England)

Published: January 02, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026